We bring together the research-based pharmaceutical industry in the UK, presenting a compelling single voice founded on a shared understanding with stakeholders and focused on delivering more effective healthcare to benefit patients, the NHS and our members.
Our key messages
We are the globally respected voice of the UK pharmaceutical industry, which is world leading in the discovery and development of vital new medicines
The pharmaceutical industry in the UK is one of our most valuable industries and is part of the solution for delivering better outcomes for patients, the NHS and the UK economy
ABPI believes that UK patients should have access to appropriate, innovative medicines, ensuring that the right patient receives the right medicines at the right time.
Our three-year strategic plan lays out our commitment to becoming world class: to surpass member’s requirements; to lead the industry through a rapidly evolving healthcare sector; to shape the UK pharmaceutical environment in order to maintain a strong R&D based industry and to ultimately ensure patients in the UK are direct beneficiaries of the most up to date advances in medicines research.
Our strategic plan is reviewed annually on a rolling basis to keep us positioned at the forefront of changes in the environment and to address any issues raised in an annual member’s survey of our performance.
For more in-depth information about our strategic plan please download: